AU Stock MarketDetailed Quotes
CYPOA Cynata Therapeutics Ltd
- 0.030
- -0.010-25.00%
20min DelayMarket Closed Nov 15 14:26 AET
5.42MMarket Cap0.00P/E (Static)
0.030High0.030Low46.67KVolume0.030Open0.040Pre Close1.40KTurnover0.10052wk High0.03%Turnover Ratio180.68MShares0.01952wk Low--EPS TTM4.11MFloat Cap0.100Historical High0.00P/E (Static)136.96MShs Float0.010Historical Low--EPS LYR0.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
About Cynata Therapeutics Ltd Company
Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus. There are currently three active clinical trials taking place using Cymerus technology which are attempting to treat osteoarthritis, respiratory distress, and diabetic foot ulcers.
Company Profile
SymbolCYPOA
Company NameCynata Therapeutics Ltd
Founded2003
MarketASX
Employees2
Fiscal Year Ends06-30
Address100 Cubitt Street Level 3
CityCremorne
CountryAustralia
Zip Code3121
Phone+61 370676940
Websitehttps://www.cynata.com
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Ross Macdonald
- Chief Executive Officer,Managing Director
- --
- Geoffrey E.D Brooke
- Non-Executive Director,Non-Executive Chairman
- --
- Paul K Wotton
- Non-Executive Director
- --
- Janine Rolfe
- Non-Executive Director
- --
- David Atkins
- Non-Executive Director
- --
- Darryl Maher
- Non-Executive Director
- --
- Stewart James Washer
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data